These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33155945)

  • 21. Thrombolytic treatment of acute pulmonary embolism.
    Charbonnier B; Meyer G; Stern M; Sors H; Brochier ML
    Herz; 1989 Jun; 14(3):157-71. PubMed ID: 2500388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial.
    Özkan M; Gündüz S; Gürsoy OM; Karakoyun S; Astarcıoğlu MA; Kalçık M; Aykan AÇ; Çakal B; Bayram Z; Oğuz AE; Ertürk E; Yesin M; Gökdeniz T; Duran NE; Yıldız M; Esen AM
    Am Heart J; 2015 Aug; 170(2):409-18. PubMed ID: 26299240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results of low-dose tissue plasminogen activator therapy in acute pulmonary embolism.
    Hezer H; Kiliç H; Abuzaina O; Hasanoǧlu HC; Karalezli A
    J Investig Med; 2019 Dec; 67(8):1142-1147. PubMed ID: 31341000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged Infusions of Low-Dose Thrombolytics in Elderly Patients With Prosthetic Heart Valve Thrombosis.
    Gündüz S; Özkan M; Yesin M; Kalçık M; Gürsoy MO; Karakoyun S; Astarcıoğlu MA; Aykan AÇ; Gökdeniz T; Biteker M; Duran NE; Yıldız M
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):241-247. PubMed ID: 26447199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic and clinical characteristics of thrombolytic agents.
    Deitcher SR; Jaff MR
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S25-33. PubMed ID: 15112713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial.
    Özkan M; Kalçık M; Gürsoy MO; Öcal L; Griffini S; Karakoyun S; Yesin M; Gündüz S; Astarcıoğlu MA; Bayam E; Cerşit S; Aykan AÇ; Cugno M
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):372-80. PubMed ID: 26657322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up.
    Meneveau N; Schiele F; Metz D; Valette B; Attali P; Vuillemenot A; Grollier G; Elaerts J; Mossard JM; Viel JF; Bassand JP
    J Am Coll Cardiol; 1998 Apr; 31(5):1057-63. PubMed ID: 9562007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction.
    Meneveau N; Schiele F; Vuillemenot A; Valette B; Grollier G; Bernard Y; Bassand JP
    Eur Heart J; 1997 Jul; 18(7):1141-8. PubMed ID: 9243149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and predictors of major hemorrhagic complications from thrombolytic therapy in patients with massive pulmonary embolism.
    Meyer G; Gisselbrecht M; Diehl JL; Journois D; Sors H
    Am J Med; 1998 Dec; 105(6):472-7. PubMed ID: 9870831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism.
    Patel DC; Gaba RC; Liu L; Lokken RP
    PLoS One; 2019; 14(2):e0211701. PubMed ID: 30726288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rare cause of myocardial infarction: acute inferoposterior myocardial infarction after successful intravenous thrombolytic treatment of mechanical mitral prosthetic valve thrombosis.
    Altinbas A; Kucuktepe Z; Ozaydin M; Aslan SM; Demir M; Altinbas E
    Int J Cardiovasc Imaging; 2005 Oct; 21(5):509-12. PubMed ID: 16175440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
    Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie AG; Gent M
    Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of thrombolytic therapy in elderly patients with massive pulmonary embolism: a comparison with nonelderly patients.
    Meneveau N; Bassand JP; Schiele F; Bouras Y; Anguenot T; Bernard Y; Schultz R
    J Am Coll Cardiol; 1993 Oct; 22(4):1075-9. PubMed ID: 8409043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety, Efficacy of an Accelerated Regimen of Low-Dose Recombinant Tissue-Type Plasminogen Activator for Reperfusion Therapy of Acute Pulmonary Embolism.
    Hoang BH; Do PG; Le LD; Bui TTH; Bui TN; Nguyen QM; To DH; Nguyen AD; Dinh MM; Goldhaber SZ; Day R; Nguyen HL
    Clin Appl Thromb Hemost; 2021; 27():10760296211037920. PubMed ID: 34514865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism.
    Tebbe U; Graf A; Kamke W; Zahn R; Forycki F; Kratzsch G; Berg G
    Am Heart J; 1999 Jul; 138(1 Pt 1):39-44. PubMed ID: 10385761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brachial embolism from mechanical mitral valve thrombosis: multimodality imaging-guided successful thrombolysis.
    Cerşit S; Bayam E; Gündüz S; Güner A; Özkan M
    Blood Coagul Fibrinolysis; 2018 Jun; 29(4):395-398. PubMed ID: 29406388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A serial fluoroscopy-guided thrombolytic therapy of a mechanical tricuspid prosthetic valve thrombosis with low-dose and ultra-slow infusion of tissue-type plasminogen activator.
    Kalçık M; Gürsoy OM; Astarcıoğlu MA; Özkan M
    Turk Kardiyol Dern Ars; 2014 Jul; 42(5):478-81. PubMed ID: 25080958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new short infusion dosage regimen of recombinant tissue plasminogen activator in patients with venous thromboembolic disease.
    Levine MN; Weitz J; Turpie AG; Andrew M; Cruickshank M; Hirsh J
    Chest; 1990 Apr; 97(4 Suppl):168S-171S. PubMed ID: 2108854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: Clinical efficacy but attendant hemorrhagic risks.
    Rothschild DP; Goldstein JA; Bowers TR
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):506-510. PubMed ID: 30549393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-Dose Systemic Alteplase (tPA) for the Treatment of Pulmonary Embolism.
    Brandt K; McGinn K; Quedado J
    Ann Pharmacother; 2015 Jul; 49(7):818-24. PubMed ID: 25857308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.